Tumor Microenvironment
A section of Cancers (ISSN 2072-6694).
Section Information
The MDPI journal Cancers has recently defined the scope and have introduced a Tumor Microenvironment Section. The TME section aims to publish high-quality research on the molecular and cellular components of cancer microenvironment, with a particular focus on basic, translational and clinical research that has significant implications for the diagnosis, prevention and treatment of human malignancies. The subject area include, but not limited to, the mechanisms playing essential role in tumor cell plasticity under the influence of unique microenvironment, molecular and cellular markers for diagnosis, prognosis, drug targets in malignant cells and its microenvironment, and the role of microbiome in influencing the etiology and characteristics of cancer cell. The section also encourages communication of scientific advancement in complementary and alternative medicines influencing tumor microenvironment.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Targeting the Tumor Microenvironment (Volume II) (Deadline: 30 April 2025)
- Role of Extracellular Vesicles in Cancer Progression (Deadline: 30 April 2025)
- Role of Cytokines in Cancer (Deadline: 30 April 2025)
- Signaling Pathways of Breast Cancer (Deadline: 30 May 2025)
- Effects of Radiotherapy on the Tumor Microenvironment (Deadline: 30 May 2025)
- Oncogenic Driver Mutations and Signaling Pathways in Tumorigenesis and Therapy in Lung Cancer (Deadline: 31 May 2025)
- Human Microbiome, Diet and Cancerogenesis (Deadline: 31 May 2025)
- Lifestyle Choices and Endocrine Dysfunction on Cancer Onset and Risk (Deadline: 1 June 2025)
- Aging and Cancers (Deadline: 30 June 2025)
- The Warburg Effect in Cancers (Deadline: 30 June 2025)
- Epigenetic Regulation in Hematologic Malignancies (Deadline: 30 June 2025)
- Advances in Bacteria and Cancer (Deadline: 15 July 2025)
- Relationship Between Protein and Metabolite in Cancers (Deadline: 20 July 2025)
- EVs and EPS in Cancer: Cell-to-Cell Communication, Diagnosis, and Evaluation of Cancer Therapy Response (Deadline: 20 July 2025)
- Targeted Therapies for Cancer Metastasis (Deadline: 31 July 2025)
- Extracellular Matrix Proteins in Cancer (Deadline: 31 July 2025)
- Epigenetic Regulation in Cancers (Deadline: 10 August 2025)
- Role of Autophagy in Cancer Stem Cells and the Tumor Microenvironment: New Frontiers in Cancer Drug Discovery (Deadline: 15 August 2025)
- Novel Insights into Microenvironment of Leukemia (Deadline: 20 August 2025)
- Radiation Exposure, Inflammation and Cancers (Deadline: 20 August 2025)
- The Role of Autophagy in Brain Tumors (Volume II) (Deadline: 31 August 2025)
- Signaling Networks Controlling Ovarian Cancer Progression and Response to Therapy (Deadline: 31 August 2025)
- Circulating Tumor Cells: Origin, Fate, and Roles in Immune Evasion and Metastasis (Deadline: 31 August 2025)
- Tumor-Initiating Cells in Breast Cancer: From Bench to Bedside (Deadline: 10 September 2025)
- Endothelial Cells in Inflammation, Tissue Repair, Ageing and Cancer: 2nd Edition (Deadline: 15 September 2025)
- MicroRNA and Cancer Immunology (Deadline: 15 September 2025)
- Tumor Microenvironment Dynamics in Hepatocellular Carcinoma (Deadline: 30 September 2025)
- The Influence of Epigenetic Regulation on the Tumor Microenvironment: Mechanisms and Therapeutic Implications (Deadline: 30 September 2025)
- Advances in Chronic Lymphocytic Leukemia Microenvironment: The Disruption of the Supportive Leukemic/Accessory Cells Interactions to Improve Therapy Response, 2nd Edition (Deadline: 30 September 2025)
- Treatment of Peripheral T-cell Lymphomas (Deadline: 15 October 2025)
- State-of-the-Art Strategies for Non-Coding RNA Function Detection and Regulation in Cancer (Deadline: 20 October 2025)
- G Protein-Coupled Receptors in Cancer Progression (Deadline: 30 October 2025)
- The Role of Genes in Prostate Cancer (Deadline: 31 October 2025)
- Heme Metabolism in Oncogenesis and Tumor Microenvironment: Mechanisms and Emerging Therapeutic Strategies (Deadline: 31 October 2025)
- Targeting TGF-β as a Marker and Pharmacological Target against Cancer (Deadline: 1 November 2025)
- Aberrant Cytokine Receptor Signaling in Hematological Cancers and Proliferative Disorders (Deadline: 20 November 2025)
- Epigenetic and Metabolic Alterations in the Tumor Microenvironment: 2nd Edition (Deadline: 21 November 2025)
- The New Challenge of Curing AML: Analysis of Mechanisms of Resistance of Target Drugs and Future Perspectives (Deadline: 30 November 2025)
- Tumor Microenvironment in Primary Liver Cancer 2nd edition (Deadline: 30 November 2025)
- Post-transcriptional Regulation of Cancer-Related Processes (Deadline: 1 December 2025)
- Latest Breakthroughs in Tumor Immune Microenvironment: From Cellular Discovery to Cutting-Edge Technology (Deadline: 5 December 2025)
- New Molecular Targets and Emerging Approaches to Target Cancer Stem Cells (Deadline: 15 December 2025)
- Genome Instability and Human Cancer (Deadline: 15 December 2025)
- A Deeper Dive into Signaling Pathways in Cancers (2nd Edition) (Deadline: 20 December 2025)
- Tumor Immune Microenvironment in Gastric Cancers (Deadline: 25 December 2025)
- Feature Papers in Section "Tumor Microenvironment" (Deadline: 31 December 2025)
- Breast Cancer Research and Treatment (Deadline: 31 December 2025)
- Hippo Signaling in Cancer (2nd Edition) (Deadline: 31 December 2025)
- State-of-the-Art Treatment on Chemotherapy and Immunotherapy for Urological Cancer (Deadline: 31 December 2025)
- Ovarian Cancer Stem Cells and Tumor Microenvironment (Deadline: 31 December 2025)
- Tumor Microenvironment of Gynecological Tumors (Deadline: 10 January 2026)
- Roles of the Tumor Microenvironment on Liquid Biopsy (2nd Edition) (Deadline: 22 January 2026)
- The Tumor Microenvironment: Interplay Between Immune Cells (Deadline: 31 January 2026)
- Lymph Node Involvement in Cervical Cancer: From Single Isolated Tumor Cell to Macrometastasis (Deadline: 31 January 2026)
- Exploring Skin Cancer: Insights into New Diagnostic, Prognostic, and Therapeutic Strategies (Deadline: 31 January 2026)
- Advanced Glycation End-Products and Its Receptors in Cancer Progression (Deadline: 31 January 2026)
- Transforming Liver Cancer Care: From Molecular Understanding to Novel Therapeutic Strategies (Deadline: 10 February 2026)
- Drug Resistance Mechanisms and Tumor Microenvironment in Upper Gastrointestinal Cancers (Deadline: 28 February 2026)
- The Role of Regucalcin in Cancer (Deadline: 1 March 2026)
- Targeted Therapy of Cholangiocarcinoma (Deadline: 19 March 2026)
- Genetic Alterations and the Tumor Microenvironment (Deadline: 31 March 2026)
- Cancer Cell Motility (2nd Edition) (Deadline: 2 April 2026)
- Advances in Cellular Heterogeneity and Plasticity in the Tumor Microenvironment (Deadline: 15 April 2026)
- Fatty Acid Synthesis and Mitochondrial Beta-Oxidation in Cancer (Deadline: 30 April 2026)
- Inhibitors in Thyroid Carcinoma (2nd Edition) (Deadline: 24 May 2026)
- The Development of Effective Therapy Targeting the Microenvironment of Cancer (2nd Edition) (Deadline: 30 September 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Deciphering the Crosstalk between Tumor Cells and Their Microenvironment: From Molecular Aspects to Therapeutic Implications
- Kinases and Cancer (Closed)
- Matrix Effectors and Cancer (Closed)
- Molecular Signaling Pathways and Networks in Cancer
- New Discoveries and Future Trend for Prostate Cancer Research and Treatment
- Targeting Solid Tumors
